This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BREAST_EXALLC for full statistics.
Carcinoma in situ of breast
CD2_INSITU_BREAST
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditions
|
269239 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
166 |
6. Filter based on genotype QC (FinnGen only) |
166 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ vulvae
Carcinoma in situ of breast
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 166 | 166 | - |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | - |
| Median age at first event (years) | 60.25 | 60.25 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 124
- Matched controls
- 1240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
194.6
99.1
96
21
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.3
19.0
34
34
PJA12
NOMESCO Finland
Sentinel node biopsy
7.4
16.7
44
86
D05.0
ICD-10 Finland
Lobular carcinoma in situ
97.7
16.0
17
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
11.6
14.4
27
29
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
8.6
13.8
31
46
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
45.4
13.5
16
*
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
18.9
12.1
18
11
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
12.2
10.7
19
18
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.9
10.6
21
25
WX402
NOMESCO Finland
General anaesthesia
4.3
10.4
44
140
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
18.7
10.2
15
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
9.6
60
261
HAB40
NOMESCO Finland
Wedge excision of mammary gland
5.3
9.0
28
64
WZC30
NOMESCO Finland
Teaching
4.6
8.4
30
80
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
10.5
8.0
15
16
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
7.9
27
68
N63
ICD-10 Finland
Unspecified lump in breast
4.8
7.5
25
62
N64.5
ICD-10 Finland
Other signs and symptoms in breast
8.9
6.5
13
16
HAC20
NOMESCO Finland
Total mastectomy
6.0
6.4
17
32
D24
ICD-10 Finland
Benign neoplasm of breast
7.0
6.1
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768793) Breast Pathology biopsy report
49
77
8.61
31.92
1.5
1.3
—
—
—
0
0
(4035726)
50
143
4.57
16.58
1.5
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
122
657
4.23
16.14
3.6
3.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
16
9.46
11.28
1.1
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
21
49
4.76
8.69
1.7
3.5
u/ml
11.9
33.7
0.90
21
49
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
16
6.59
6.03
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
73
430
2.25
5.97
1.8
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
323
2.16
4.97
1.9
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
63
384
2.03
4.46
1.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
91
648
1.89
3.96
2.4
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
104
779
1.90
3.81
5.4
5.6
umol/l
9.0
9.7
0.84
98
736
(3019550) Sodium [Moles/volume] in Serum or Plasma
160
1464
3.57
3.20
14.2
13.7
mmol/l
139.9
139.9
0.02
160
1420
(3023103) Potassium [Moles/volume] in Serum or Plasma
160
1468
3.49
3.04
14.4
13.7
mmol/l
3.9
3.9
0.21
160
1421
(3002256) Pathology report gross observation
35
200
1.95
2.85
1.5
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
96
740
1.71
2.84
4.7
5.6
mmol/l
1.2
1.2
0.21
84
625
(3013650) Neutrophils [#/volume] in Blood by Automated count
106
840
1.72
2.83
7.2
8.6
e9/l
3.9
3.9
0.13
89
729
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
87
2.34
2.69
2.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
20
3.61
2.08
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
121
1.94
2.00
2.3
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
21
3.43
1.99
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
21
3.43
1.99
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
22
3.27
1.90
1.4
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
22
3.27
1.90
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
22
3.27
1.90
1.6
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
22
3.27
1.90
1.6
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
116
1.93
1.89
2.0
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
76
600
1.49
1.75
4.7
3.7
g/l
37.0
35.9
0.99
70
558
(3018418) pH of Serum or Plasma
62
471
1.50
1.71
3.8
3.6
ph
7.4
7.4
0.23
12
84
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
32
2.57
1.62
1.1
1.2
—
—
—
0
0
(3013512) EKG study
55
416
1.48
1.53
3.6
3.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
155
1449
2.05
1.51
4.9
4.9
mmol/l
3.0
2.9
0.38
147
1338
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
45
2.30
1.49
1.0
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
52
2.19
1.48
1.0
1.3
—
2.4
—
0
10
(3000494) Fungus identified in Specimen by Culture
26
167
1.66
1.45
1.2
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
39
2.38
1.45
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
147
1356
1.73
1.45
3.9
3.9
mmol/l
1.3
1.2
0.23
140
1245
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
22
2.79
1.45
1.0
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
53
2.15
1.42
1.0
1.3
—
4.2
—
0
13
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
305
1.50
1.41
1.1
1.3
iu/ml
12.8
34.1
—
8
113
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
148
1371
1.73
1.39
12.3
11.6
ml/min/173m2
83.7
81.4
0.77
126
1117
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
153
1431
1.88
1.38
4.4
4.4
mmol/l
5.0
4.9
0.37
147
1330
(3042936) Bacteria identified in Isolate by Culture
28
188
1.59
1.32
2.0
1.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
43
2.15
1.32
1.0
1.2
—
51.0
—
0
5
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
81
673
1.40
1.32
4.7
5.0
mmol/l
1.2
1.2
0.57
74
606
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
34
2.42
1.31
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
18
2.83
1.29
1.4
1.2
nmol/l
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
35
2.35
1.29
1.4
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
47
356
1.45
1.28
4.6
6.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
27
182
1.58
1.26
1.6
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
1533
2.21
1.23
11.5
10.0
u/l
24.6
23.9
0.21
160
1477
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
11
57
2.00
1.20
1.0
1.3
—
1.2
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
72
1.87
1.19
1.2
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
168
1.57
1.18
3.0
3.7
ug/l
2.0
8.9
1.80
17
139
(3044889) 12 lead EKG panel
115
1024
1.40
1.18
3.6
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
42
316
1.44
1.18
1.4
1.6
mg/l
0.7
1.0
0.81
29
249
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
34
0.00
1.17
0.0
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
194
1.53
1.17
4.1
4.1
%
32.5
34.1
0.32
22
122
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
20
2.54
1.16
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
20
2.54
1.16
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
157
1496
1.91
1.16
13.7
11.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
58
1.96
1.15
1.1
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
151
1422
1.68
1.11
4.4
4.4
mmol/l
1.6
1.6
0.01
144
1314
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
21
2.42
1.10
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
21
139
1.58
1.06
2.9
3.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
123
1.62
1.05
1.7
3.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
23
2.21
0.98
1.4
1.2
nmol/l
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
31
0.00
0.97
0.0
1.1
—
2.0
—
0
18
(3008037) Lactate [Moles/volume] in Venous blood
6
29
2.11
0.90
1.2
2.6
mmol/l
1.6
1.3
—
6
29
(3029937) Albumin [Presence] in Urine by Test strip
29
381
0.71
0.89
4.8
3.7
estimate
0.0
0.0
—
9
137
(3033658) Prothrombin time (PT) actual/Normal
44
352
1.34
0.86
3.0
3.1
%
102.9
97.6
0.82
44
339
(3015736) pH of Urine
64
542
1.29
0.84
3.4
3.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
56
467
1.30
0.82
5.9
4.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
24
0.00
0.80
0.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
34
1.79
0.77
1.3
1.1
—
—
—
0
0
(4010399)
6
108
0.54
0.75
1.8
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
520
1.27
0.75
2.1
3.4
mmol/l
2.4
2.4
0.87
52
458
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
38
1.88
0.74
1.7
3.4
mmol/l
24.6
25.4
—
7
38
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
25
2.03
0.73
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
60
512
1.27
0.73
2.7
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
58
1.58
0.71
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
27
1.88
0.69
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
27
1.88
0.69
1.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
73
642
1.24
0.68
9.4
8.0
e9/l
0.0
0.0
0.65
64
521
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
141
1339
1.35
0.67
5.6
5.2
mmol/mol
39.2
39.1
0.04
132
1244
(3022621) pH of Urine by Test strip
6
102
0.57
0.64
2.0
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
30
1.69
0.62
1.2
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.61
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
22
0.00
0.60
0.0
1.6
—
5.5
—
0
22
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
44
370
1.26
0.59
3.0
2.9
mg/l
13.5
216.1
0.55
29
217
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
37
443
0.79
0.59
1.8
1.7
mmol/l
1.4
1.3
0.25
37
377
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
150
1.38
0.59
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
23
0.00
0.58
0.0
2.3
—
60.5
—
0
23
(3037522) Nuclear Ab [Titer] in Serum
27
214
1.31
0.57
1.4
1.4
titre
213.3
699.6
—
6
53
(3021960) Folate [Moles/volume] in Serum or Plasma
26
324
0.77
0.57
1.5
1.4
nmol/l
23.4
22.6
0.06
20
267
(3019060) Gas panel - Arterial blood
11
74
1.52
0.55
2.0
6.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
133
0.66
0.54
1.0
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
23
180
1.32
0.53
1.3
1.6
s
29.0
29.5
0.22
23
175
(3007164) IgA [Mass/volume] in Serum or Plasma
26
321
0.77
0.53
1.9
1.3
g/l
1.8
2.2
—
10
193
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
64
1.43
0.52
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
83
755
1.20
0.52
6.0
5.2
e9/l
0.2
0.2
0.68
74
658
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
44
376
1.23
0.52
1.6
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
46
396
1.22
0.51
2.7
2.8
mmol/l
6.2
7.0
0.69
41
325
(3022313) Gas panel - Capillary blood
7
45
1.58
0.49
1.7
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
146
1407
1.31
0.49
4.7
4.4
mmol/l
5.9
5.8
0.60
136
1303
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
47
1.51
0.48
2.4
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
31
257
1.25
0.48
3.3
3.4
ng/l
71.5
404.7
0.72
24
185
(40761536) Microorganisms panel - Urine sediment
8
116
0.67
0.47
2.5
3.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
152
0.70
0.46
1.6
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
69
1.48
0.45
1.3
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
58
517
1.19
0.44
6.8
6.1
inr
1.2
1.1
0.38
15
166
(3037467) Urinalysis macro (dipstick) panel - Urine
105
984
1.18
0.44
4.5
4.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
118
1117
1.20
0.44
4.9
4.0
mm/h
11.3
11.7
0.13
112
1028
(3020682) Albumin/Creatinine [Ratio] in Urine
45
393
1.20
0.43
3.2
3.6
mg/mmol
5.5
5.7
0.01
29
220
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
28
331
0.81
0.40
1.9
2.4
umol/l
308.0
6405.4
1.81
21
286
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
18
0.00
0.40
0.0
1.2
—
6.9
—
0
12
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
80
738
1.16
0.40
6.1
4.8
e9/l
1.9
2.1
0.55
72
649
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
32
273
1.21
0.39
1.9
2.7
e6/l
6.8
6.2
0.10
26
242
(1002224) Polysomnography panel
9
67
1.36
0.39
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
98
1.35
0.39
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
36
312
1.20
0.37
1.3
1.3
u/ml
6.1
8.7
0.20
14
128
(3003338) MCHC [Mass/volume]
126
1207
1.18
0.37
16.8
16.0
g/l
331.4
330.8
0.28
126
1200
(3000963) Hemoglobin [Mass/volume] in Blood
161
1581
1.61
0.36
20.8
18.4
g/l
133.8
132.4
0.91
161
1555
(3035941) MCH [Entitic mass]
161
1580
1.63
0.36
20.6
18.2
pg
30.1
30.2
0.18
161
1556
(3024731) MCV [Entitic volume]
161
1580
1.63
0.36
20.7
18.2
fl
90.8
91.1
0.44
161
1556
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
42
1.44
0.36
1.8
1.5
mu/l
375.8
285.8
—
6
37
(3001604) Monocytes [#/volume] in Blood
78
723
1.15
0.35
6.3
4.8
e9/l
0.6
0.5
0.39
70
620
(40760892) CBC W Ordered Manual Differential panel - Blood
28
326
0.83
0.35
4.2
4.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
118
1.30
0.35
1.3
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
78
724
1.15
0.35
6.3
4.8
e9/l
0.0
0.0
0.31
70
620
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
87
0.68
0.34
1.2
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
326
1.17
0.32
4.2
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
269
1.19
0.32
1.8
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
120
1.27
0.31
1.9
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
140
1435
0.84
0.28
13.3
12.1
mg/l
15.5
20.1
1.75
119
1087
(3000492) Spirometry study
15
122
1.25
0.28
1.4
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
10
127
0.77
0.26
2.0
4.7
u/l
214.7
254.0
—
10
120
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
123
1.24
0.26
1.9
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
75
0.66
0.26
1.2
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
313
1.15
0.26
4.0
3.6
kg/l
1.0
1.0
—
5
46
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
218
1.17
0.25
1.9
2.6
e6/l
1.1
1.0
0.06
14
117
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
59
550
1.11
0.23
2.2
1.9
pmol/l
100.7
100.2
0.03
30
255
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.8
1.5
g/l
0.0
0.0
—
5
40
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.8
1.6
g/l
0.0
0.1
—
5
40
(4094501)
5
40
1.26
0.22
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
41
1.23
0.22
1.4
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
173
1.18
0.22
1.4
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
11
0.00
0.21
0.0
1.7
—
11.2
—
0
11
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
4.6
—
0
11
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
11
0.00
0.21
0.0
4.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
18.6
—
0
11
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
0.6
—
0
11
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
38
347
1.12
0.21
2.1
2.7
ng/l
303.7
1015.0
3.55
32
288
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(4027681)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
1.3
—
0
7
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(4034850)
6
49
1.23
0.20
1.7
6.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
213
1.15
0.20
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
88
917
0.91
0.19
3.2
3.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
2.3
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
69
0.72
0.17
3.6
2.8
u/ml
13.4
1915.6
—
5
62
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
8
68
1.19
0.17
1.6
2.9
kpa
5.1
5.2
—
8
61
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
30
276
1.11
0.15
2.5
2.6
mmol/l
2.5
2.5
0.04
24
240
(3041096) Erythrocytes [Presence] in Urine by Automated
37
396
0.92
0.14
2.4
3.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
84
1.20
0.14
4.1
6.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
84
1.20
0.14
1.1
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
11
128
0.85
0.14
3.2
2.1
g/l
0.2
0.2
0.56
11
119
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
33
308
1.09
0.12
2.4
2.0
mg/l
2.2
3.1
2.27
27
265
(3009542) Hematocrit [Volume Fraction] of Blood
132
1298
1.08
0.12
15.0
13.2
%
37.9
39.3
0.78
100
967
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
182
1.11
0.11
1.8
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
372
0.93
0.11
1.5
1.2
u/ml
0.5
2.6
—
9
110
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
123
1207
1.07
0.11
6.0
4.3
pmol/l
14.7
14.6
0.10
115
1114
(40761535) Cells panel - Urine sediment
12
105
1.15
0.11
3.0
3.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
74
716
1.06
0.11
3.5
3.6
estimate
0.0
0.0
—
9
129
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
69
667
1.06
0.10
2.6
2.2
nmol/l
80.8
79.3
0.17
61
595
(3035350) Ketones [Presence] in Urine by Test strip
73
707
1.06
0.10
3.5
3.6
estimate
0.0
0.0
—
8
133
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
10
87
1.16
0.09
1.1
2.7
ng/l
51.6
126.7
—
10
79
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
47
1.07
0.09
1.4
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
47
1.07
0.09
1.4
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
204
1.09
0.09
1.9
2.8
e6/l
2.1
4.3
0.89
11
103
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
67
1.05
0.08
1.1
2.1
u/l
31.4
41.1
—
7
59
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
67
1.05
0.08
1.3
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
71
0.84
0.08
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
38
364
1.06
0.07
2.4
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
14
128
1.10
0.07
2.2
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
183
0.92
0.07
6.0
4.6
—
—
—
0
0
(3026782) Osmolality of Urine
27
256
1.07
0.06
1.7
2.8
mosm/kgh2o
485.8
524.2
0.32
20
222
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
496
0.95
0.06
2.7
3.2
ng/l
10.5
31.2
1.73
29
315
(3023368) Bacteria identified in Blood by Culture
30
313
0.95
0.05
3.5
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
53
544
0.96
0.05
3.5
3.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
110
1.10
0.05
1.3
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
10
109
0.91
0.04
1.3
2.4
e9/l
4.6
4.1
—
10
89
(3014111) Lactate [Moles/volume] in Serum or Plasma
11
103
1.07
0.02
4.1
5.3
mmol/l
1.1
1.2
0.17
11
98
(3030467) Casts [#/volume] in Urine by Automated count
38
372
1.03
0.02
2.4
3.0
e6/l
0.1
0.5
1.62
28
271
(3019309) Folate [Moles/volume] in Red Blood Cells
24
233
1.04
0.01
2.3
1.6
nmol/l
980.4
1169.5
0.52
17
171
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
126
0.95
0.00
1.3
1.2
iu/ml
152.0
173.3
—
6
57
(3002582) Erythrocytes [#/volume] in Urine
41
404
1.02
0.00
2.4
3.2
e6/l
14.5
66.6
1.78
31
303
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
199
1.01
0.00
2.3
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
10
97
1.03
0.00
1.0
3.0
mmol/l
4.3
2.3
—
10
82
(3012544) pH of Venous blood
11
107
1.03
0.00
1.0
3.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
12
123
0.97
0.00
1.6
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
153
0.98
0.00
1.5
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
45
447
1.01
0.00
2.4
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
50
495
1.01
0.00
3.1
3.7
e6/l
106.3
78.0
0.12
32
328
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
47
468
1.01
0.00
2.6
3.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
115
1.05
0.00
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
71
711
1.00
0.00
5.0
5.0
estimate
0.0
0.0
—
8
133
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
10.0
—
1036.6
—
0
7
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
12.6
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
12.6
—
1916.9
—
0
7
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
9.0
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.0
—
5.6
—
0
9
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.2
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
31.6
—
0
8
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2286.6
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
55
0.91
0.00
1.8
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
83
0.96
0.00
1.8
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
31.8
—
0
8
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
69
1.02
0.00
3.7
8.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
55
0.91
0.00
1.8
1.4
g/l
3.5
3.8
—
5
43
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
55
0.91
0.00
1.8
1.4
g/l
6.9
7.8
—
5
46
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
5
51
0.98
0.00
1.0
3.2
mmol/l
28.4
24.4
—
5
46
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
93.9
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
4.3
—
44.3
—
0
6
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
83
0.96
0.00
1.5
2.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
122
1220
1.00
0.00
17.8
15.2
%
13.5
13.7
0.79
122
1201
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
50
1.00
0.00
1.8
1.4
g/l
2.4
3.2
—
5
43
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
160.5
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
2.5
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
49
1.02
0.00
1.4
3.3
%
33.7
46.6
—
5
49
(3020630) Protein [Mass/volume] in Serum or Plasma
10
100
1.00
0.00
1.4
2.6
g/l
67.6
67.5
—
10
95
(3000330) Specific gravity of Urine by Test strip
7
70
1.00
0.00
1.6
3.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST – Carcinoma in situ of breast
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).